Corteva, Inc. (CTVA)
Pre-market:
| Previous close | 55.20 |
| Open | 54.67 |
| Bid | 54.12 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 54.67 - 55.57 |
| 52-week range | 43.22 - 61.87 |
| Volume | |
| Avg. volume | 3,608,780 |
| Market cap | 38.564B |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | 42.45 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.64 (1.16%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- PR Newswire
Corteva Launches Corteva Catalyst
Corteva, Inc. (NYSE: CTVA) today announced the launch of Corteva Catalyst, a new investment and partnership platform focused on accessing and bringing to market agricultural innovations that advance the company's R&D priorities and drive value creation. Corteva Catalyst will partner with entrepreneurs and innovators to accelerate the development of early-stage, disruptive technologies that enable farmers to sustainably produce more food and feed.
- PR Newswire
Corteva Announces Dates for First Quarter 2024 Earnings Release and Webcast
Corteva, Inc. (NYSE: CTVA) today announced it will release its first quarter 2024 earnings on Wednesday, May 1, 2024, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Thursday, May 2, 2024, at 9:00 a.m. Eastern Time.
- PR Newswire
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announces today that it has achieved a milestone in the collaboration with Corteva Agriscience (NYSE: CTVA), a leading pure-play agriculture company, for the development of novel herbicides. The milestone marks the successful identification of a new family of molecules exhibiting herbicidal effect through a novel Mode of Action (MoA),
